Phibro Animal Health Management
Management criteria checks 2/4
Phibro Animal Health's CEO is Jack Bendheim, appointed in Jan 1988, has a tenure of 36.92 years. total yearly compensation is $4.75M, comprised of 49.6% salary and 50.4% bonuses, including company stock and options. directly owns 49.94% of the company’s shares, worth $438.69M. The average tenure of the management team and the board of directors is 7.1 years and 15.5 years respectively.
Key information
Jack Bendheim
Chief executive officer
US$4.8m
Total compensation
| CEO salary percentage | 49.6% |
| CEO tenure | 36.9yrs |
| CEO ownership | 49.9% |
| Management average tenure | 7.1yrs |
| Board average tenure | 15.5yrs |
Recent management updates
Recent updates
Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
Nov 25
There May Be Reason For Hope In Phibro Animal Health's (NASDAQ:PAHC) Disappointing Earnings
Nov 13Phibro Animal Health Corporation's (NASDAQ:PAHC) Shares Bounce 26% But Its Business Still Trails The Industry
Sep 14Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 29Phibro Animal Health (NASDAQ:PAHC) Will Pay A Dividend Of $0.12
Aug 15New Forecasts: Here's What Analysts Think The Future Holds For Phibro Animal Health Corporation (NASDAQ:PAHC)
May 14Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
May 11Phibro Animal Health: An Interesting Deal With Zoetis For A Struggling Business
May 01Market Participants Recognise Phibro Animal Health Corporation's (NASDAQ:PAHC) Earnings Pushing Shares 30% Higher
Apr 30Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Phibro Animal Health (NASDAQ:PAHC) Use Of Debt Could Be Considered Risky
Dec 06Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Nov 10A Look At The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)
Nov 05Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Aug 28Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12
Jul 29Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12
Feb 10Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?
Dec 23Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12
Aug 26Phibro Animal Non-GAAP EPS of $0.36 misses by $0.02, revenue of $255.3M beats by $5.26M
Aug 24Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?
Aug 24Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12
Jul 29Phibro Animal declares $0.12 dividend
Jul 25Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12
May 06CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$17m |
| Jun 30 2024 | US$5m | US$2m | US$2m |
| Mar 31 2024 | n/a | n/a | US$13m |
| Dec 31 2023 | n/a | n/a | US$15m |
| Sep 30 2023 | n/a | n/a | US$21m |
| Jun 30 2023 | US$3m | US$2m | US$33m |
| Mar 31 2023 | n/a | n/a | US$29m |
| Dec 31 2022 | n/a | n/a | US$36m |
| Sep 30 2022 | n/a | n/a | US$46m |
| Jun 30 2022 | US$4m | US$2m | US$49m |
| Mar 31 2022 | n/a | n/a | US$59m |
| Dec 31 2021 | n/a | n/a | US$53m |
| Sep 30 2021 | n/a | n/a | US$49m |
| Jun 30 2021 | US$4m | US$2m | US$54m |
| Mar 31 2021 | n/a | n/a | US$43m |
| Dec 31 2020 | n/a | n/a | US$44m |
| Sep 30 2020 | n/a | n/a | US$43m |
| Jun 30 2020 | US$3m | US$2m | US$34m |
| Mar 31 2020 | n/a | n/a | US$37m |
| Dec 31 2019 | n/a | n/a | US$38m |
| Sep 30 2019 | n/a | n/a | US$41m |
| Jun 30 2019 | US$3m | US$2m | US$55m |
| Mar 31 2019 | n/a | n/a | US$68m |
| Dec 31 2018 | n/a | n/a | US$73m |
| Sep 30 2018 | n/a | n/a | US$65m |
| Jun 30 2018 | US$3m | US$2m | US$65m |
Compensation vs Market: Jack's total compensation ($USD4.75M) is above average for companies of similar size in the US market ($USD3.30M).
Compensation vs Earnings: Jack's compensation has increased by more than 20% whilst company earnings have fallen more than 20% in the past year.
CEO
Jack Bendheim (77 yo)
36.9yrs
Tenure
US$4,753,878
Compensation
Mr. Jack Clifford Bendheim has been the President and Chief Executive Officer of Phibro Animal Health Corporation since 1988 and March 2014, respectively and serves as its Chairman. Mr. Bendheim served as...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 36.9yrs | US$4.75m | 49.94% $ 438.7m | |
| Chief Financial Officer | less than a year | US$2.40m | no data | |
| Chief Operating Officer | 8.4yrs | US$3.42m | 0.074% $ 650.7k | |
| Executive VP of Corporate Strategy & Director | 10.8yrs | US$763.24k | no data | |
| President of North America Region | 5.6yrs | US$752.70k | no data | |
| Senior VP | 1.4yrs | no data | no data | |
| Senior Vice President of Human Resources | 7.8yrs | no data | no data | |
| President of MACIE Region | no data | no data | no data | |
| President South America Region | 7.5yrs | no data | no data | |
| President of Asia Pacific Region | 1.7yrs | no data | no data | |
| President of PhibroChem and Ethanol Performance Group | no data | no data | no data | |
| VP of Finance & Treasurer | 6.8yrs | no data | no data |
7.1yrs
Average Tenure
55yo
Average Age
Experienced Management: PAHC's management team is seasoned and experienced (7.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 40.9yrs | US$4.75m | 49.94% $ 438.7m | |
| Executive VP of Corporate Strategy & Director | 11.1yrs | US$763.24k | no data | |
| President of MACIE Region | 6.3yrs | no data | no data | |
| Independent Non-Executive Director | 20.9yrs | US$60.00k | no data | |
| Independent Non Executive Director | 20.6yrs | US$40.00k | no data | |
| Independent Director | 14.4yrs | US$60.00k | 0.0025% $ 21.7k | |
| Independent Non-Executive Director | 16.6yrs | US$50.00k | 0.062% $ 542.2k | |
| Independent Director | 1.8yrs | US$50.00k | no data |
15.5yrs
Average Tenure
65yo
Average Age
Experienced Board: PAHC's board of directors are seasoned and experienced ( 15.5 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 02:14 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/06/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Phibro Animal Health Corporation is covered by 15 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Balaji Prasad | Barclays |
| Matthew Korn | Barclays |
| Douglas Tsao | Barclays |